The Colebil and Panzcebil pills, removed from pharmacies: The National Agency for Medicines blocks the sale

The National Agency for Medicines (ANM) has decided to ban the sale of Colebil and Panzcebil pills, used for treating digestive and biliary disorders. This measure was communicated by the manufacturer, who specified that the ban is temporary and will last until the necessary documentation for the two products is clarified.

The sale of these medications has been blocked throughout the distribution chain, including in pharmacies. Although the company did not provide specific details about the documentation requested by ANM, it assured that the products continue to meet quality and safety standards for patients. This situation raises questions regarding pharmaceutical regulations and the impact on patients who depend on these medications.